TKNO · Alpha Teknova, Inc.
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| $43.7M | $40.52M | $37.75MG | $36.68M | $41.42MG | $36.89M | $31.3M | |
| -$872K | -$710K | -$687K | -$833K | $213K | -$589K | $87K | |
| $28.58M | $27.08M | $30.51M | $26.39M | $23.94M | $19.27M | $13.54M | |
| $15.12M | $13.44M | $7.23M | $10.3M | $17.48M | $17.62M | $17.76M | |
| — | 33.17% | 19.16% | 28.07% | 42.19% | 47.76% | 56.73% | |
| $2.23M | $2.2M | $2.76M | $5.57M | $7.74M | $4.31M | $1.51M | |
| $7.79M | $6.75M | $6.32M | $9.33M | $9.15M | $3.78M | $2.23M | |
| $19.77M | $20.32M | $23.15M | $25.45M | $28.3M | $20.39M | $8.21M | |
| $1.15M | $1.15M | $1.15M | $1.15M | $1.15M | $1.15M | $1.15M | |
| $6.34M | $6.34M | $6.58M | $5.66M | $3.17M | $2.88M | $2.04M | |
| $30.93M | $30.42M | $33.38M | $45.86M | $67.14M | $29.63M | $13.09M | |
| -$15.81M | -$16.98M | -$26.15M | -$35.56M | -$49.66M | -$12.01M | $4.66M | |
| — | -41.9% | -69.27% | -96.94% | -119.89% | -32.55% | 14.9% | |
| -$9.47M | -$10.63M | -$19.57M | -$29.9M | -$46.49M | -$9.13M | $6.71M | |
| -$861K | -$225K | -$687K | -$1.52M | $268K | -$629K | $63K | |
| -$16.68M | -$17.2M | -$26.83M | -$37.08M | -$49.39M | -$12.64M | $4.73M | |
| $94K | $58K | -$88K | -$298K | -$1.92M | -$2.83M | $1.16M | |
| -$16.77M | -$17.26M | -$26.75M | -$36.78M | -$47.47M | -$9.8M | $3.57M | |
| — | -42.59% | -70.86% | -100.26% | -114.6% | -26.57% | 11.41% | |
| — | — | — | — | — | -$9.8M | $608K | |
| USD/shares | -$0.30 | -$0.32 | -$0.57 | -$1.16 | -$1.69 | -$0.61 | $0.17 |
| USD/shares | -$0.30 | -$0.32 | -$0.57 | -$1.16 | -$1.69 | -$0.61 | $0.16 |
| shares | — | 53.48M | 46.75M | 31.82M | 28.08M | 16.09M | 3.6M |
| shares | — | 53.48M | 46.75M | 31.82M | 28.08M | 16.09M | 3.8M |
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 48 similar-size Drug Manufacturers - Specialty & Generic companies (of 95 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| United States | $38,249,000 | $35,919,000 | $35,000,000 | $40,103,000 | $35,808,000 | $30,138,000 |
| Non Us | $2,271,000 | $1,826,000 | $1,684,000 | $1,317,000 | $1,085,000 | $1,159,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Lab Essentials | $31,044,000 | $28,883,000 | $28,800,000 | $31,772,000 | $27,184,000 | $21,240,000 |
| Clinical Solutions | $7,650,000 | $7,097,000 | $6,738,000 | $8,445,000 | $6,793,000 | $4,807,000 |
| Other Product | $1,826,000 | $1,765,000 | $1,146,000 | $1,203,000 | $1,386,000 | $953,000 |
| Sample Transport | — | — | — | — | $1,530,000 | $4,297,000 |